BEAT
HeartBeam, Inc. (NASDAQ)
Healthcare — Health Information Services
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
Price History
Fundamentals
| Market Cap | $40.48M |
| P/E Ratio (TTM) | - |
| Forward P/E | -1.38 |
| EPS (TTM) | $-0.56 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | -495.62% |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | $3.83 |
| Analysts | 3 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 46.0 |
| Beta | -0.87 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $4.00 |
| 52-Week Low | $0.54 |
| 50-Day Avg | $0.84 |
| 200-Day Avg | $1.41 |
| Avg Volume | 963.8K |
| Volume | 357.1K |
Performance Analysis
NEUTRALBEAT presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 12:59 UTC
Back to Screener Export Report